154 related articles for article (PubMed ID: 36729117)
1. Vaccine effectiveness estimates from an early-season influenza A(H3N2) epidemic, including unique genetic diversity with reassortment, Canada, 2022/23.
Skowronski DM; Chuang ES; Sabaiduc S; Kaweski SE; Kim S; Dickinson JA; Olsha R; Gubbay JB; Zelyas N; Charest H; Bastien N; Jassem AN; De Serres G
Euro Surveill; 2023 Feb; 28(5):. PubMed ID: 36729117
[TBL] [Abstract][Full Text] [Related]
2. Paradoxical clade- and age-specific vaccine effectiveness during the 2018/19 influenza A(H3N2) epidemic in Canada: potential imprint-regulated effect of vaccine (I-REV).
Skowronski DM; Sabaiduc S; Leir S; Rose C; Zou M; Murti M; Dickinson JA; Olsha R; Gubbay JB; Croxen MA; Charest H; Bastien N; Li Y; Jassem A; Krajden M; De Serres G
Euro Surveill; 2019 Nov; 24(46):. PubMed ID: 31771709
[TBL] [Abstract][Full Text] [Related]
3. Influenza vaccine effectiveness against A(H3N2) during the delayed 2021/22 epidemic in Canada.
Kim S; Chuang ES; Sabaiduc S; Olsha R; Kaweski SE; Zelyas N; Gubbay JB; Jassem AN; Charest H; De Serres G; Dickinson JA; Skowronski DM
Euro Surveill; 2022 Sep; 27(38):. PubMed ID: 36148674
[TBL] [Abstract][Full Text] [Related]
4. Influenza Vaccine Effectiveness by A(H3N2) Phylogenetic Subcluster and Prior Vaccination History: 2016-2017 and 2017-2018 Epidemics in Canada.
Skowronski DM; Leir S; Sabaiduc S; Chambers C; Zou M; Rose C; Olsha R; Dickinson JA; Winter AL; Jassem A; Gubbay JB; Drews SJ; Charest H; Chan T; Hickman R; Bastien N; Li Y; Krajden M; De Serres G
J Infect Dis; 2022 Apr; 225(8):1387-1398. PubMed ID: 32215564
[TBL] [Abstract][Full Text] [Related]
5. 2023/24 mid-season influenza and Omicron XBB.1.5 vaccine effectiveness estimates from the Canadian Sentinel Practitioner Surveillance Network (SPSN).
Skowronski DM; Zhan Y; Kaweski SE; Sabaiduc S; Khalid A; Olsha R; Carazo S; Dickinson JA; Mather RG; Charest H; Jassem AN; Levade I; Hasso M; Zelyas N; Gao R; Bastien N
Euro Surveill; 2024 Feb; 29(7):. PubMed ID: 38362622
[TBL] [Abstract][Full Text] [Related]
6. Low 2018/19 vaccine effectiveness against influenza A(H3N2) among 15-64-year-olds in Europe: exploration by birth cohort.
Kissling E; Pozo F; Buda S; Vilcu AM; Gherasim A; Brytting M; Domegan L; Gómez V; Meijer A; Lazar M; Vučina VV; Dürrwald R; van der Werf S; Larrauri A; Enkirch T; O'Donnell J; Guiomar R; Hooiveld M; Petrović G; Stoian E; Penttinen P; Valenciano M;
Euro Surveill; 2019 Nov; 24(48):. PubMed ID: 31796152
[TBL] [Abstract][Full Text] [Related]
7. A Perfect Storm: Impact of Genomic Variation and Serial Vaccination on Low Influenza Vaccine Effectiveness During the 2014-2015 Season.
Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Krajden M; Gubbay JB; Drews SJ; Martineau C; Eshaghi A; Kwindt TL; Bastien N; Li Y
Clin Infect Dis; 2016 Jul; 63(1):21-32. PubMed ID: 27025838
[TBL] [Abstract][Full Text] [Related]
8. Early season co-circulation of influenza A(H3N2) and B(Yamagata): interim estimates of 2017/18 vaccine effectiveness, Canada, January 2018.
Skowronski DM; Chambers C; De Serres G; Dickinson JA; Winter AL; Hickman R; Chan T; Jassem AN; Drews SJ; Charest H; Gubbay JB; Bastien N; Li Y; Krajden M
Euro Surveill; 2018 Feb; 23(5):. PubMed ID: 29409570
[TBL] [Abstract][Full Text] [Related]
9. Influenza Vaccine Effectiveness Against Influenza A(H3N2)-Related Illness in the United States During the 2021-2022 Influenza Season.
Price AM; Flannery B; Talbot HK; Grijalva CG; Wernli KJ; Phillips CH; Monto AS; Martin ET; Belongia EA; McLean HQ; Gaglani M; Mutnal M; Geffel KM; Nowalk MP; Tartof SY; Florea A; McLean C; Kim SS; Patel MM; Chung JR
Clin Infect Dis; 2023 Apr; 76(8):1358-1363. PubMed ID: 36504336
[TBL] [Abstract][Full Text] [Related]
10. Interim estimates of 2016/17 vaccine effectiveness against influenza A(H3N2), Canada, January 2017.
Skowronski DM; Chambers C; Sabaiduc S; Dickinson JA; Winter AL; De Serres G; Drews SJ; Jassem A; Gubbay JB; Charest H; Balshaw R; Bastien N; Li Y; Krajden M
Euro Surveill; 2017 Feb; 22(6):. PubMed ID: 28205503
[TBL] [Abstract][Full Text] [Related]
11. On the lookout for influenza viruses in Italy during the 2021-2022 season: Along came A(H3N2) viruses with a new phylogenetic makeup of their hemagglutinin.
Galli C; Pellegrinelli L; Giardina F; Ferrari G; Uceda Renteria SC; Novazzi F; Masi E; Pagani E; Piccirilli G; Mauro MV; Binda S; Corvaro B; Tiberio C; Lalle E; Maggi F; Russo C; Ranno S; Vian E; Pariani E; Baldanti F; Piralla A;
Virus Res; 2023 Jan; 324():199033. PubMed ID: 36581046
[TBL] [Abstract][Full Text] [Related]
12. Influenza vaccine effectiveness in preventing laboratory-confirmed influenza in outpatient settings: A test-negative case-control study in Beijing, China, 2016/17 season.
Wu S; Pan Y; Zhang X; Zhang L; Duan W; Ma C; Zhang Y; Zhang M; Sun Y; Yang P; Wang Q; Ma J
Vaccine; 2018 Sep; 36(38):5774-5780. PubMed ID: 30087046
[TBL] [Abstract][Full Text] [Related]
13. Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season.
Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay J; Fonseca K; Charest H; Krajden M; Petric M; Mahmud SM; Van Caeseele P; Bastien N; Eshaghi A; Li Y
J Infect Dis; 2015 Sep; 212(5):726-39. PubMed ID: 25784728
[TBL] [Abstract][Full Text] [Related]
14. Influenza vaccine effectiveness against influenza A subtypes in Europe: Results from the 2021-2022 I-MOVE primary care multicentre study.
Kissling E; Pozo F; Martínez-Baz I; Buda S; Vilcu AM; Domegan L; Mazagatos C; Dijkstra F; Latorre-Margalef N; Kurečić Filipović S; Machado A; Lazar M; Casado I; Dürrwald R; van der Werf S; O'Donnell J; Linares Dopido JA; Meijer A; Riess M; Višekruna Vučina V; Rodrigues AP; Mihai ME; Castilla J; Goerlitz L; Falchi A; Connell J; Castrillejo D; Hooiveld M; Carnahan A; Ilić M; Guiomar R; Ivanciuc A; Maurel M; Omokanye A; Valenciano M;
Influenza Other Respir Viruses; 2023 Jan; 17(1):e13069. PubMed ID: 36702797
[TBL] [Abstract][Full Text] [Related]
15. Changes in genetically drifted H3N2 influenza A viruses and vaccine effectiveness in adults 65 years and older during the 2016/17 season in Denmark.
Trebbien R; Fischer TK; Krause TG; Nielsen L; Nielsen XC; Weinreich LS; Lis-Tønder J; Skov MN; Christiansen CB; Emborg HD
J Clin Virol; 2017 Sep; 94():1-7. PubMed ID: 28697450
[TBL] [Abstract][Full Text] [Related]
16. Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses.
Skowronski DM; Janjua NZ; De Serres G; Sabaiduc S; Eshaghi A; Dickinson JA; Fonseca K; Winter AL; Gubbay JB; Krajden M; Petric M; Charest H; Bastien N; Kwindt TL; Mahmud SM; Van Caeseele P; Li Y
PLoS One; 2014; 9(3):e92153. PubMed ID: 24667168
[TBL] [Abstract][Full Text] [Related]
17. Predominance of influenza virus A(H3N2) 3C.2a1b and A(H1N1)pdm09 6B.1A5A genetic subclades in the WHO European Region, 2018-2019.
Melidou A; Hungnes O; Pereyaslov D; Adlhoch C; Segaloff H; Robesyn E; Penttinen P; Olsen SJ;
Vaccine; 2020 Jul; 38(35):5707-5717. PubMed ID: 32624252
[TBL] [Abstract][Full Text] [Related]
18. Genetic characterisation of the influenza viruses circulating in Bulgaria during the 2019-2020 winter season.
Korsun N; Trifonova I; Voleva S; Grigorova I; Angelova S
Virus Genes; 2021 Oct; 57(5):401-412. PubMed ID: 34156583
[TBL] [Abstract][Full Text] [Related]
19. A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season.
Skowronski DM; Janjua NZ; De Serres G; Winter AL; Dickinson JA; Gardy JL; Gubbay J; Fonseca K; Charest H; Crowcroft NS; Fradet MD; Bastien N; Li Y; Krajden M; Sabaiduc S; Petric M
Clin Infect Dis; 2012 Aug; 55(3):332-42. PubMed ID: 22539661
[TBL] [Abstract][Full Text] [Related]
20. Trivalent inactivated influenza vaccine effective against influenza A(H3N2) variant viruses in children during the 2014/15 season, Japan.
Sugaya N; Shinjoh M; Kawakami C; Yamaguchi Y; Yoshida M; Baba H; Ishikawa M; Kono M; Sekiguchi S; Kimiya T; Mitamura K; Fujino M; Komiyama O; Yoshida N; Tsunematsu K; Narabayashi A; Nakata Y; Sato A; Taguchi N; Fujita H; Toki M; Myokai M; Ookawara I; Takahashi T
Euro Surveill; 2016 Oct; 21(42):. PubMed ID: 27784529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
